Stockreport

FDA rejects Vanda's Hetlioz for jet lag disorder [Seeking Alpha]

Vanda Pharmaceuticals Inc.  (VNDA) 
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm Check Earnings Report
PDF Vanda Pharmaceuticals (NASDAQ: VNDA ) has received a CR L from the FDA regarding its marketing application seeking approval to use HETLIOZ (tasimelteon) to trea [Read more]